SEC FORM 4
$66,321.50
Bicara Therapeutics Inc. (BCAX)
Acquisition (code M) of 17,500 shares at $3.7898 per share.
Reporting Person Cohlhepp Ryan · Officer Title President, COO & Interim CEO · Transaction Code M
Traded Sep 8, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001470831-26-000883 · filed 2026-09-10 · View filing →